The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects

By Ding Yi   Jia YanYan   Song Ying   Lu ChengTao   Li YuWen   Chen MinChun   Wang MingMing   Wen AiDong  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 141-146

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects

By Yin Ophelia Q.P.  

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 169-179

Adis International

Access to resources Recommend Favorite

The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects

By Xu Hong-Rong   Chen Wei-Li   Li Xue-Ning   Chu Nan-Nan  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 8, 2010-08 ,pp. : 947-952

Informa Healthcare

Access to resources Recommend Favorite

Effect of Repeated Doses of Darunavir plus Low-Dose Ritonavir on the Pharmacokinetics of Sildenafil in Healthy Male Subjects: Phase I Randomized, Open-Label, Two-Way Crossover Study

By Sekar V.  

Clinical Drug Investigation, Vol. 28, Iss. 8, 2008-01 ,pp. : 479-485

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations: A Randomized, Open-Label, Two-Treatment, Two-Period, Two-Sequence, Single-Dose, Crossover, Bioequivalence Study

By Kandhwal Kirti  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 853-863

Adis International

Access to resources Recommend Favorite